抗<I>α</I>-フェトプロテインモノクローナル抗体をキャリアとするイムノトキシン
スポンサーリンク
概要
- 論文の詳細を見る
A monoclonal antibody (MoAb) against <I>α</I>-fetoprotein (AFP), 80G, was obtained by the cell fusion technique. This MoAb was quite difficult to inhibit with free AFP. Complexation of 80G with AFP did not lead to rapid clearance of 80G from circulation, and these immune complexes remained capable of binding to solidphase AFP. Furthermore, pharmacokinetic analysis showed the suitability of MoAb 80G as an active targeting carrier. These results encouraged us to further evaluate the potency of our MoAb 80G as a carrier for targeting AFP-producing hepatoma cells. Four immunotoxins composed of MoAb 80G and a type 1 ribosome-inactivating protein, gelonin, were prepared. They involve two disulfide-linked and two thioether-linked immunotoxins. These immunotoxins (190 kDa) were purified by using a combination of gel filtration and affinity chromatography. The binding activity of immunotoxins against AFP remained as high as that of intact 80G. The <I>in vitro</I> cytotoxic effects of all the immunotoxins were specific against AFP-producing human hepatoma cell line, HuH-7. Of these irnmunotoxins, two containing gelonin modified with 2-iminothiolane were more potent than the others. They showed selective antitumor activity against AFP-producing HuH-7N cells in nude mice(HuH-7 xenograft). However, the disulfide immunotoxin was more toxic to mice than the thioether immunotoxin. These results suggest that our MoAb 80G is a suitable carrier for targeting AFT-producing hepatoma cells, and that our non-cleavable thioether immunotoxin is promising as an AFT-producing hepatomatargeted drug delivery system.
論文 | ランダム
- ALSへの呼吸理学療法と気道管理 (特集 非侵襲的呼吸療法ガイドラインのスタート)
- 小児歯科 永久中切歯の歯軸傾斜と歯列弓の発育的変化との関係について (最近の歯学)
- 歯列弓長の前方成長に対する永久中切歯の歯軸傾斜ならびにその位置移動の関与に関する経年的研究
- P1-188 外来がん化学療法における制吐剤としてのブロマゼパム坐剤の有効性について(一般演題 ポスター発表,がん薬物療法(副作用対策),医療薬学の創る未来 科学と臨床の融合)
- 末梢神経障害 (血液がん患者の治療と看護--看護師ががんチーム医療のレベルアップに貢献するために) -- (抗がん剤投与に伴う合併症の管理と看護)